Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Contemp Clin Trials. 2018 Nov 8;76:1–8. doi: 10.1016/j.cct.2018.11.007

Table 1:

Key Characteristics by Parent Trial

BASC MOVE IT
Parent trial participants Daily smokers with current or lifetime major depressive disorder. Adults admitted for inpatient care on general medicine or oncology units.
Parent trial intervention Two behavioral interventions in combination with varenicline Supportive social incentive-based gamification intervention in the three months post-hospital discharge. Hospital-implemented mobility protocol using wearable technology.
Parent trial outcome(s) Point-prevalence abstinence post- target quit date. Change in mean daily step count.
Is there a separate step to screen for RETAIN-specific eligibility? Yes
Patients are probed for prior knowledge of incentive randomization, equalization, or the maximum amount offered under RETAIN.
No
Do patients actively consent to RETAIN ? No
A waiver of consent for RETAIN has been approved by the IRB.
No
A waiver of consent for RETAIN has been approved by the IRB.
Can anyone enroll in the parent trial without enrolling in RETAIN? Yes, if they screen ineligible specifically for RETAIN No
Incentive for parent trial subjects not enrolled in RETAIN Up to $200 Not applicable
Incentive levels None: $0
Moderate: $200
High: $500
None: $0
Moderate: $100
High: $300
Debriefing Plan On the phone, before the first day of the assigned intervention for the parent trial. In-person, during the same encounter as all RETAIN procedures and prior to beginning the assigned intervention for the parent trial.
Payments to subjects consented to RETAIN and the parent trial $300 in two $150 installments, plus up to $200 from individual session/travel payments.1 $300 in two $150 installments